HONG KONG, Aug 13, 2024 – PawNovo, an innovator in veterinary diagnostics, announced its first appearance at the International Animal Veterinary Conference (IAVC), showcasing its commitment to advancing veterinary diagnostics with the launch of the Nous 30V fully automated molecular diagnostic system (referred as to Nous 30V), along with over 50 reagents for cats and dogs.

PawNovo aims to become a global leader in veterinary diagnostics, by offering molecular in vitro diagnostic equipment and reagents for animals. With a strong R&D capability, the company is poised to bring cutting-edge diagnostic products and services to the market.

Nous 30V is PawNovo’ s total solution for point-of-care testing (POCT) molecular diagnostics in pet hospitals and clinics. It is designed for high efficiency and sensitivity, enabling rapid and accurate nucleic acid testing. The analyzer integrates magnetic bead-based nucleic acid extraction and quantitative fluorescence polymerase chain reaction (qPCR) technologies to deliver rapid results. The nucleic acid extraction, purification and amplification processes are carried out in a closed system, ensuring isolation from the external environment. Prefilled extraction reagents and lyophilized PCR mix allow room temperature transportation and storage. With minimal manual involvement and a fully automatic process from samples to results in as quick as 30 minutes, it considerably reduces the turnaround time.

Visitors at the IAVC were immersed in PawNovo’s diagnostic solutions that embody the company's commitment to innovation and excellence in animal healthcare. The company's entry into the Hong Kong market is a strategic move to meet the growing demand for high-quality veterinary diagnostic solutions. PawNovo is dedicated to improving the accuracy and efficiency of pet disease detection, thereby contributing to the early discovery and diagnosis of pet diseases.

About PawNovo

Dongguan PawNovo Biotech Co., Ltd. ("PawNovo") is a subsidiary of Fapon Biotech, specializing in veterinary diagnostics. Our expertise spans research and development, production, sales, and customer service for diagnostic instruments and reagents. We provide high-performance point-of-care PCR products along with comprehensive technical support tailored for veterinary hospitals, large breeders, and research institutions. Backed by our team of seasoned experts, we are dedicated to innovation and aim to become a global leader in veterinary diagnostics, ensuring the health and well-being of animals.